CD19+ B cell depletion and reduced IL-6, TNF- α, RF (not found after treatment) and ACPAs (35,6- to 865-fold) levels. RA-related antibodies were significantly reduced for 6 months.B cell reconstitution was observed from 60 to 90 days. Here, CD19 is linked to rheumatoid arthritis.